Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

The burden of hepatocellular carcinoma (HCC) is highest in East Asia and Africa, although
its incidence and mortality are rapidly rising in the United States and Europe. With the …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …

Hepatocellular cancer (HCC) is the fourth leading cause of cancer-related deaths worldwide
and the fastest growing cause of cancer deaths in the United States. The overall prognosis …

Background and Aims Hepatocellular carcinoma (HCC) surveillance is associated with early
tumor detection and improved survival; however, it is often underused in clinical practice. We …

Background and Aims Patients with cirrhosis are at increased risk of postoperative mortality.
Currently available tools to predict postoperative risk are suboptimally calibrated and do not …

The term acute‐on‐chronic liver failure (ACLF) is intended to identify patients with chronic
liver disease who develop rapid deterioration of liver function and high short‐term mortality …

Artificial intelligence (AI) and machine learning (ML) systems are increasingly used in
medicine to improve clinical decision-making and healthcare delivery. In gastroenterology …

Portal vein tumor thrombus (PVTT) is a significant poor prognostic factor for hepatocellular
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein …

Hepatocellular carcinoma (HCC) is a leading cause of global cancer death. Major etiologies
of HCC relate to chronic viral infections as well as metabolic conditions. The survival rate of …